ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RNXT vs FBIO // EV/EBITDA & P/E VALUATION

RenovoRx Inc. (NASDAQ) VS. Fortress Biotech Inc. (NASDAQ) • 15-METRIC TALLY: RNXT 4 — FBIO 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. FBIO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RNXT FBIO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.90% 66.90% +4.00 RNXT /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -16.32% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% 58.50% -118.50 FBIO /net-margins <GO>
Revenue Growth (YoY) 180.00% 9.70% +170.30 RNXT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 1.00% -1.00 FBIO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.40 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 FBIO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.1 38.7 +8.43 RNXT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.2M $66.7M $541.0K RNXT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RNXT REV FBIO REV RNXT GROSS % FBIO GROSS % RNXT FCF FBIO FCF
FY 2025 $1.1M $63.3M 70.9% 66.9% -$11.0M -$65.8M
FY 2024 $43.0K $57.7M 98.0% 63.8% -$9.1M -$80.2M
FY 2023 $0 $84.5M — — -$10.3M -$128.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
FBIO // BETA —